Distribution of neural cell adhesion molecule (NCAM/CD56) in gastrointestinal stromal tumours and their intra-abdominal mesenchymal mimics
- 8 October 2007
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 61 (4), 499-503
- https://doi.org/10.1136/jcp.2007.052696
Abstract
Background:The distribution and reactivity pattern of neural cell adhesion molecule (NCAM/CD56) in gastrointestinal stromal tumours (GISTs) and their mesenchymal mimics have not been investigated in the KIT era.Methods:275 histologically and immunohistochemically well characterised primary and metastatic intra-abdominal mesenchymal lesions were analysed by conventional immunohistochemistry, with emphasis on GIST and GI smooth muscle neoplasms.Results:CD56 expression was seen in 18/21 (86%), 4/5 (80%), 26/34 (76%), and 32/168 (19%) of primary GI leiomyomas, schwannomas, leiomyosarcomas, and GISTs, respectively. Reactivity in GISTs was mostly focal. Of 6% strongly staining GISTs, 71% were either malignant clinically or assigned a high risk prognostic group. CD56 expression in GISTs varied greatly with histological type (seen in 50% and 7% of epithelioid and spindled GISTs, respectively) and anatomical site (in 33%, 10%, 1%, and 0% of rectal, gastric, small intestinal and oesophageal GISTs, respectively). A variable, but inconsistent expression was seen in miscellaneous lesions including dedifferentiated liposarcoma, abdominopelvic PEComa, myo/fibroblastic sarcoma and malignant fibrous histiocytoma. Mesenteric fibromatoses, angiosarcoma/Kaposi sarcoma, reactive tumefactive fibrogenic lesions and 12/13 primary anorectal and oesophageal melanomas were negative.Conclusion:Results confirmed the ubiquity and non-specificity of CD56 as a neurogenic marker. Except for a subset of epithelioid gastric and high-grade rectal GISTs, CD56 expression is rare in GISTs, contrasting with true leiomyomatous and neurogenic neoplasms. CD56 plays a limited role in the differential diagnosis of GIST. Its potential role as a marker of adverse outcome in GISTs remains to be further investigated.Keywords
This publication has 13 references indexed in Scilit:
- Gastrointestinal stromal tumors: Pathology and prognosis at different sitesSeminars in Diagnostic Pathology, 2006
- Immunohistochemical analysis of E-cadherin, -catenin, -catenin, -catenin, and neural cell adhesion molecule (NCAM) in chordomaJournal of Clinical Pathology, 2001
- Proximal-Type Epithelioid Sarcoma: A Clinicopathologic Study of 20 CasesLaboratory Investigation, 2001
- Expression of neural cell adhesion molecules and neurofilament protein isoforms in skeletal muscle tumorsHuman Pathology, 1998
- Poorly Differentiated Synovial SarcomaThe American Journal of Surgical Pathology, 1998
- Adhesion molecules in skeletogenesis: II. Neural cell adhesion molecules mediate precartilaginous mesenchymal condensations and enhance chondrogenesisJournal of Cellular Physiology, 1993
- Neural cell adhesion molecule distribution in soft tissue tumorsHuman Pathology, 1993
- Towards the phenotyping of soft tissue tumours by cell surface moleculesVirchows Archiv A Pathological Anatomy and Histopathology, 1991
- Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.The Journal of Experimental Medicine, 1989
- Neural Cell Adhesion Molecule: Structure, Immunoglobulin-Like Domains, Cell Surface Modulation, and Alternative RNA SplicingScience, 1987